title: Ocular ischemic syndrome presenting as central retinal artery occlusion in scleroderma.
authors.affiliation: Department of Ophthalmology, Gazi University, Medical Faculty, Besevler, Ankara, Turkey. okonuk@gazi.edu.tr
authors.forename: Onur
authors.initials: O
authors.lastname: Konuk
authors.forename: Sengül
authors.initials: S
authors.lastname: Ozdek
authors.forename: Baran
authors.initials: B
authors.lastname: Onal
authors.forename: Yudum
authors.initials: Y
authors.lastname: Tiftikçioğlu
authors.forename: Gökhan
authors.initials: G
authors.lastname: Gürelik
authors.forename: Berati
authors.initials: B
authors.lastname: Hasanreisoğlu
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D002343:Carotid Artery, Internal / Q000473:pathology*; D016893:Carotid Stenosis / Q000175:diagnosis* / Q000188:drug therapy; D017023:Coronary Angiography; D004359:Drug Therapy, Combination; D005123:Eye / Q000098:blood supply*; D005260:Female; D005451:Fluorescein Angiography; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007511:Ischemia / Q000175:diagnosis* / Q000188:drug therapy; D015356:Retinal Artery Occlusion / Q000175:diagnosis* / Q000188:drug therapy; D045743:Scleroderma, Diffuse / Q000175:diagnosis* / Q000188:drug therapy; D013577:Syndrome; D018608:Ultrasonography, Doppler; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin